Last reviewed · How we verify

TR987 0.1% gel + Standard of Care — Competitive Intelligence Brief

TR987 0.1% gel + Standard of Care (TR987 0.1% gel + Standard of Care) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Dermatology.

phase 3 Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

TR987 0.1% gel + Standard of Care (TR987 0.1% gel + Standard of Care) — TR Therapeutics. TR987 0.1% gel works by targeting the existing mechanism of standard of care to enhance its effects.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
TR987 0.1% gel + Standard of Care TARGET TR987 0.1% gel + Standard of Care TR Therapeutics phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). TR987 0.1% gel + Standard of Care — Competitive Intelligence Brief. https://druglandscape.com/ci/tr987-0-1-gel-standard-of-care. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: